Brief: Indaptus Therapeutics Activates Morristown Medical Center As New Clinical Trial Site For Treatment Of Advanced Solid Tumors
Feb 7 (Reuters) - Indaptus Therapeutics Inc INDP.O :
* INDAPTUS THERAPEUTICS ACTIVATES MORRISTOWN MEDICAL CENTER
AS
TRIAL SITE IN INDP-D101, ITS ONGOING PHASE 1 OPEN LABEL CLINICAL
TRIAL OF DECOY20 IN PATIENTS WITH ADVANCED SOLID TUMORS
Source text for Eikon: ID:nGNX2gc1tf
Further company coverage: INDP.O